The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

AbbVie said that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections on Friday.

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

EBR Systems is super confident the US medical gatekeeper will approve Wise, the world's first wireless pacemaker device.

The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...